Commercial executive, previously Head of Inflammatory diseases, Europe at Pfizer. UK, EMEA and Global experience in emerging and established, biotech and pharmaceutical sectors, including pre-IPO. Demonstrable track record of building and leading commercial, access and medical teams to create and execute portfolio strategy.

Serial entrepreneur, experienced in recruiting and supervising strong management teams. Extensive senior management roles including successful fund-raising, commercial deals and company trade sales.

Clinician with extensive research interests in pharmacognosy specifically focused on immunomodulatory phyto-pharmaceuticals and the roles they play in inflammation and the resolution of inflammation.

Clinical Scientist with wide ranging experience across a number of therapeutic areas. Previously European Clinical Science Director Inflammation for Wyeth/Pfizer responsible for providing European input into global research and publication strategies and leading health economic submissions to NICE.

Partner in Anvil Partners LLP since 1995, advising companies on private equity transactions and mergers & acquisitions. Previously 18 years in investment banking in London, New York, and Paris with Kleinwort Benson and qualified as a chartered accountant with Price Waterhouse.

35 years experience in the pharma industry. Former Regulatory Affairs Manager, Lederle Laboratories before becoming Licensing & Acquisition Manager, Lederle Laboratories. Currently GM Subiaco Associates Ltd, Healthcare Regulatory Consultancy.